Our mission is to improve the quality of preventive medicine, practitioner productivity, patient care and physical performance through nanotechnology-enabled diagnostic monitoring.
2013 Cloth-based Nanosensor technology invented, first patent awarded.
2014 Nanowear founded.
2016 Nanowear receives first 510(k) clearance from US FDA for SimplECG(TM) utilizing cloth-based nanotechnology, native iOS application and physician web portal.
2017 Nanowear participates in equity-free MedTech Innovator, StartX and PlugNPlay accelerator programs.
2018 Nanowear wins Accenture’s HealthTech Challenge Global Champion at 36th annual JPMorgan Healthcare Conference.
2018 Nanowear wins Best in Show and Best Health and Wearable Company at SXSW Pitch.
2019 Series A round raised.
2019 Nanowear scales manufacturing of heart failure alert diagnostic product "SimpleSense".
2019 Launches NanoSENSE clinical study at Penn State Hershey Medical Center and Hackensack Meridian Health programs.